| Literature DB >> 15193300 |
Henrik H Hansen1, Tim Briem, Mark Dzietko, Marco Sifringer, Alexander Voss, Wojciech Rzeski, Barbara Zdzisinska, Friederike Thor, Rolf Heumann, Andrzej Stepulak, Petra Bittigau, Chrysanthy Ikonomidou.
Abstract
The developing rodent brain is vulnerable to pharmacological blockade of N-methyl-d-aspartate (NMDA) receptors which can lead to severe and disseminated apoptotic neurodegeneration. Here, we show that systemic administration of the NMDA receptor antagonist MK801 to 7-day-old rats leads to impaired activity of extracellular signal-regulated kinase 1/2 (ERK1/2) and reduces levels of phosphorylated cAMP-responsive element binding protein (CREB) in brain regions which display severe apoptotic neurodegeneration. Impaired ERK1/2 and CREB activity were temporally paralleled by sustained depletion of neurotrophin expression, particularly brain-derived neurotrophic factor (BDNF). BDNF supplementation fully prevented MK801-induced neurotoxicity in immature neuronal cultures and transgenic constitutive activation of Ras was associated with marked protection against MK801-induced apoptotic neuronal death. These data indicate that uncoupling of NMDA receptors from the ERK1/2-CREB signaling pathway in vivo results in massive apoptotic deletion of neurons in the developing rodent brain.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15193300 DOI: 10.1016/j.nbd.2004.03.013
Source DB: PubMed Journal: Neurobiol Dis ISSN: 0969-9961 Impact factor: 5.996